ESO Voice of Stroke
European Stroke Organisation
0
Voice of Stroke is a podcast by the European Stroke Organisation that provides monthly updates on stroke research. Each episode highlights key papers from leading medical journals and discusses their implications for clinical practice. The show offers concise, evidence-based takeaways from breakthrough trials and cross-disciplinary insights.
Episodes
-
Beyond Reperfusion — Adjunctive Therapies in Acute Ischaemic Stroke 17.11.2026 12mRestoring blood flow is central to acute ischaemic stroke treatment. But even after successful thrombolysis or thrombectomy, many patients are left with significant disability. Could additional treatments help improve outcomes? In the latest Voice of Stroke podcast episode, we explore new evidence on adjunctive therapies aimed at improving outcomes alongside reperfusion treatment, from early antiplatelet strategies to therapeutic hypothermia. This episode discusses: The TAPIS trial and whether early dual antiplatelet therapy after thrombolysis can improve functional outcomes New evidence from... -
Unmasking the Aetiology of Cryptogenic Stroke: Can Imaging Help? 20.10.2026 12mEmbolic stroke of undetermined source (ESUS) accounts for a substantial proportion of ischaemic strokes. But could new imaging techniques help uncover the causes that conventional investigations have missed? In the latest Voice of Stroke podcast episode, we explore three recent studies examining how advanced imaging, carotid plaque assessment and thrombus composition may help identify the underlying mechanisms of cryptogenic stroke. This episode discusses: A novel PET imaging technique that may directly identify the source of thrombosis in patients with ischaemic stroke Whether CT angiography... -
Thrombectomy for Medium or Distal Vessel Occlusion – In Search of Green Flags 22.09.2026 12mMedium or distal vessel occlusions account for up to a third of ischaemic stroke, but recent randomised trials have raised important questions about the role of thrombectomy in these patients. In the latest Voice of Stroke podcast episode, we explore new evidence searching for the "green flags" that could help identify patients with medium or distal vessel occlusion who may benefit from thrombectomy. This episode discusses: • The ORIENTAL-MeVO trial and thrombectomy in patients with moderate-to-severe neurological deficits • Whether baseline imaging and collateral status may help identify diff... -
Redrawing the Limits of Thrombectomy: Dose, Damage, and Delay 25.08.2026 12mEndovascular thrombectomy has transformed the treatment of large vessel occlusion stroke. But as its use expands, important questions remain about where its boundaries lie. In this episode of Voice of Stroke, we explore three recent studies examining patient selection and treatment intensity at the margins of thrombectomy practice. This episode discusses: • The CHOICE-2 trial and adjunctive intra-arterial alteplase after successful thrombectomy • Whether ischaemic core volume may refine patient selection beyond ASPECTS in large-core stroke • The AURORA pooled analysis examining the role of tim... -
Small Vessels, Big Questions – Biomarkers, Cerebrovascular Autoregulation and Emerging Therapeutic Targets in Cerebral Small Vessel Disease 28.07.2026 12mCerebral small vessel disease is increasingly recognised as one of the leading causes of stroke, cognitive impairment and dementia worldwide. Despite its enormous clinical impact, disease-modifying therapies remain limited. In this episode of Voice of Stroke, we explore how advances in biomarker discovery and cerebrovascular physiology are reshaping our understanding of cSVD and identifying promising new therapeutic targets. This episode discusses: The global burden of cerebral small vessel disease Cerebrospinal fluid and blood biomarkers for disease characterisation and progression Cerebral a... -
Blood Pressure Control: Which Patients May Benefit Most From Specific Strategies? 23.06.2026 12mHow should clinicians think about hypertension in 2026? In this episode of Voice of Stroke, we explore recent evidence addressing one of the most important questions in vascular prevention: not simply whether to lower blood pressure, but which treatments work best, who should be treated, and how hypertension-related vascular disease may influence stroke mechanisms and secondary prevention. This episode discusses: Meta-analyses evaluating the efficacy and tolerability of antihypertensive drugs and combinations Blood pressure lowering in isolated diastolic hypertension An exploratory analysis of... -
Intracerebral Haemorrhage – From Blood Pressure Control to Secondary Brain Injury 28.05.2026 12mIn this episode of Voice of Stroke we explore major recent advances in intracerebral haemorrhage research. This episode discusses: The TRIDENT trial and long-term blood pressure lowering after ICH Perihaematomal oedema growth as a biomarker of secondary brain injury Translational neuroimmunology and inflammatory signalling after haemorrhage Highlights from the ESO ICH Academy Meeting in Maastricht Featuring discussion of recent publications in the New England Journal of Medicine, Stroke, and Annals of Neurology. Written by Voice of Stroke Podcast Editor-in-Chief Linxin Li and Co-editor Annemij... -
Atrial Fibrillation and Stroke Prevention – What's New? 23.04.2026 10mIn this episode of Voice of Stroke, we explore the latest evidence shaping stroke prevention in atrial fibrillation (AF) – a condition responsible for up to a quarter of all ischaemic strokes. This episode examines emerging strategies and unresolved questions in AF management, including: Whether left atrial appendage closure (LAAC) can replace anticoagulation in patients eligible for oral therapy The role of catheter ablation in reducing recurrent stroke risk after AF-related stroke New population data on blood pressure control and stroke risk, particularly in younger AF patients Key insights:... -
What's new in the field of lipids, and can it help us prevent stroke? 24.03.2026 10mIn this episode of Voice of Stroke, we explore new evidence shaping how lipid management can reduce stroke risk across both primary and secondary prevention. This episode explores: Reassessing statin side effects using large-scale randomised trial data The role of PCSK9 inhibition (VESALIUS-CV) in reducing vascular events in high-risk patients without prior stroke Long-term data linking LDL, lipoprotein(a), and inflammation to stroke risk decades later Together, these findings clarify safety concerns, expand preventive options, and highlight the importance of long-term risk prediction in strok... -
Beyond the Window – What ISC 2026 Tells Us About Treating Stroke Earlier or Later 24.02.2026 10mIn this first episode of Voice of Stroke, we examine three key trials presented at ISC 2026 that challenge how we define time boundaries in acute stroke care. This episode explores: · Extending intravenous thrombolysis beyond 4.5 hours in non-large vessel occlusion stroke (OPTION) · Tenecteplase within 24 hours for basilar artery occlusion (TRACE-5) · Ultra-early recombinant factor VIIa in intracerebral haemorrhage (FASTEST) Together, these trials refine our understanding of patient selection, risk, and benefit across ischaemic and haemorrhagic stroke. This month's Voice of Stroke episode was... -
Welcome to the Voice of Stroke Podcast 09.02.2026Welcome to Voice of Stroke, brought to you by the European Stroke Organisation. Your fast, reliable update on the science driving stroke care forward. Each month, we spotlight key papers from the world's leading journals and discuss how it can inform and refine clinical practice. From breakthrough randomised controlled trials to cross-disciplinary insights, Voice of Stroke brings you concise, evidence-based takeaways — straight from the front lines of research.
Popular in
The podcast also appears in the podcast charts of these countries.